Therma Bright Inc. (TBRIF)
USD 0.02
(-1.41%)
USD 0.02
(-1.41%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 25.39 Thousand CAD | -71.91% |
| 2022 | 90.38 Thousand CAD | 125.97% |
| 2021 | 40 Thousand CAD | 0.0% |
| 2020 | 40 Thousand CAD | -49.98% |
| 2019 | 79.96 Thousand CAD | -57.24% |
| 2018 | 187.01 Thousand CAD | -16.11% |
| 2017 | 222.93 Thousand CAD | -62.84% |
| 2016 | 600 Thousand CAD | 0.0% |
| 2015 | 600 Thousand CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | -100.0% |
| 2006 | 1.08 Million CAD | 111.49% |
| 2005 | 515.14 Thousand CAD | 0.0% |
| 2004 | - CAD | -100.0% |
| 2003 | 21.6 Thousand CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 10.72 Thousand CAD | 0.0% |
| 2024 Q1 | 18.25 Thousand CAD | 0.0% |
| 2024 Q3 | 2749.00 CAD | 0.0% |
| 2023 Q1 | 84.65 Thousand CAD | -6.35% |
| 2023 Q3 | 32.12 Thousand CAD | -16.74% |
| 2023 Q4 | 25.39 Thousand CAD | -20.97% |
| 2023 Q2 | 38.59 Thousand CAD | -54.41% |
| 2023 FY | 25.39 Thousand CAD | -71.91% |
| 2022 Q1 | 40 Thousand CAD | 0.0% |
| 2022 FY | 90.38 Thousand CAD | 125.97% |
| 2022 Q4 | 90.38 Thousand CAD | 125.97% |
| 2022 Q2 | 40 Thousand CAD | 0.0% |
| 2022 Q3 | 40 Thousand CAD | 0.0% |
| 2021 Q1 | 40 Thousand CAD | 0.0% |
| 2021 Q4 | 40 Thousand CAD | 0.0% |
| 2021 Q3 | 40 Thousand CAD | 0.0% |
| 2021 Q2 | 40 Thousand CAD | 0.0% |
| 2021 FY | 40 Thousand CAD | 0.0% |
| 2020 Q2 | 88.7 Thousand CAD | 5.31% |
| 2020 Q3 | 129.48 Thousand CAD | 45.98% |
| 2020 FY | 40 Thousand CAD | -49.98% |
| 2020 Q4 | 40 Thousand CAD | -69.11% |
| 2020 Q1 | 84.23 Thousand CAD | 5.33% |
| 2019 Q1 | 78.48 Thousand CAD | -58.03% |
| 2019 Q2 | 85.83 Thousand CAD | 9.37% |
| 2019 Q3 | 87.94 Thousand CAD | 2.45% |
| 2019 Q4 | 79.96 Thousand CAD | -9.07% |
| 2019 FY | 79.96 Thousand CAD | -57.24% |
| 2018 FY | 187.01 Thousand CAD | -16.11% |
| 2018 Q1 | 222.93 Thousand CAD | 0.0% |
| 2018 Q3 | 196 Thousand CAD | 0.0% |
| 2018 Q2 | - CAD | -100.0% |
| 2018 Q4 | 187.01 Thousand CAD | -4.58% |
| 2017 FY | 222.93 Thousand CAD | -62.84% |
| 2017 Q2 | 600 Thousand CAD | 0.0% |
| 2017 Q3 | 222.93 Thousand CAD | -62.84% |
| 2017 Q4 | 222.93 Thousand CAD | 0.0% |
| 2017 Q1 | 600 Thousand CAD | 0.0% |
| 2016 FY | 600 Thousand CAD | 0.0% |
| 2016 Q1 | 600 Thousand CAD | 0.0% |
| 2016 Q3 | 600 Thousand CAD | 0.0% |
| 2016 Q2 | 600 Thousand CAD | 0.0% |
| 2016 Q4 | 600 Thousand CAD | 0.0% |
| 2015 Q2 | 628.96 Thousand CAD | 0.0% |
| 2015 Q4 | 600 Thousand CAD | 0.0% |
| 2015 FY | 600 Thousand CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q3 | - CAD | -100.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q4 | - CAD | -100.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q3 | 1.67 Million CAD | 6.04% |
| 2009 Q2 | 1.58 Million CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2007 Q1 | 1.19 Million CAD | 9.49% |
| 2007 Q2 | - CAD | -100.0% |
| 2007 FY | - CAD | -100.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2006 Q4 | 1.08 Million CAD | -15.57% |
| 2006 Q3 | 1.29 Million CAD | 4.39% |
| 2006 FY | 1.08 Million CAD | 111.49% |
| 2006 Q2 | 1.23 Million CAD | 131.1% |
| 2006 Q1 | 534.86 Thousand CAD | 3.83% |
| 2005 FY | 515.14 Thousand CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q4 | 515.14 Thousand CAD | 0.0% |
| 2004 Q2 | 20 Thousand CAD | 0.0% |
| 2004 FY | - CAD | -100.0% |
| 2004 Q1 | 20 Thousand CAD | 400.0% |
| 2004 Q3 | - CAD | -100.0% |
| 2003 FY | 21.6 Thousand CAD | 0.0% |
| 2003 Q1 | 21.6 Thousand CAD | 20.0% |
| 2003 Q4 | 4000.00 CAD | -33.33% |
| 2003 Q3 | 6000.00 CAD | 0.0% |
| 2003 Q2 | 6000.00 CAD | -72.22% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q3 | 165.16 Thousand CAD | -15.16% |
| 2002 Q4 | 18 Thousand CAD | -89.1% |
| 2002 Q2 | 194.66 Thousand CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.992% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 99.865% |
| Össur hf. | 311.8 Million USD | 99.992% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 279.4 Thousand USD | 90.912% |
| Aurora Spine Corporation | 1.59 Million USD | 98.405% |
| BrainsWay Ltd. | 239 Thousand USD | 89.376% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 94.351% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 99.848% |
| BioElectronics Corporation | 12.52 Million USD | 99.797% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | 88.331% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | 41.863% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 95.891% |
| Avitar, Inc. | 3.89 Million USD | 99.348% |
| Nanomix Corporation | 10.11 Million USD | 99.749% |
| Theraclion SA | 1.95 Million EUR | 98.698% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | 91.664% |
| NewCardio, Inc. | - USD | -Infinity% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | 83.072% |
| Lombard Medical, Inc. | 28.02 Million USD | 99.909% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.972% |
| Vycor Medical, Inc. | 243.28 Thousand USD | 89.563% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.997% |
| VMS Rehab Systems, Inc. | 106.45 USD | -23753.452% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 95.031% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 95.23% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 95.696% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 94.839% |
| IR-Med Inc. | 161 Thousand USD | 84.229% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | 82.16% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Polarean Imaging plc | 74.84 Thousand USD | 66.074% |
| ECGI Holdings, Inc. | 804 Thousand USD | 96.842% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 92.124% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | 78.121% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 94.098% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 99.089% |
| SS Innovations International, Inc. | 1.91 Million USD | 98.671% |
| Urologix, Inc. | 4.58 Million USD | 99.446% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.999% |
| NIOX Group Plc | 500 Thousand USD | 94.922% |
| Fuse Medical, Inc. | 200 Thousand USD | 87.304% |
| Broncus Holding Corporation | 1.22 Million USD | 97.925% |
| Brain Scientific Inc. | 7378.00 USD | -244.158% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | 84.313% |
| Health Logic Interactive Inc. | - USD | -Infinity% |